Proactive Investors - Arecor Therapeutics PLC's subsidiary, Tetris Pharma, has launched in Austria its emergency injector that treats severe, low blood sugar levels in diabetics.
Ogluo is a glucagon-filled ready-to-use pen that treats hypoglycemia in both children and adults.
The latest roll-out is the second in Europe after Germany. There are an estimated 450,000 adults living with diabetes in Austria.
Tetris Pharma is currently in discussions with various health authorities across Europe to coordinate launches in additional major European countries.
Dr Shafiq Choudhary, Tetris' managing director, said: "In Austria, people living with diabetes will now be able to receive Ogluo to tackle severe hypoglycemic events, enabling patients and those around them to act quickly when such an event happens.
“With this launch in Austria, we look forward to expanding our reach within Europe over the coming months to bring this new treatment to people living with diabetes."